Market Tracker

10/21 6:06am ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

15.52
Data as of Oct 20
 +0.15 / +0.98%
Today’s Change
10.01
Today|||52-Week Range
18.48
+19.85%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close15.37
Today’s open15.33
Day’s range-- - --
Volume923,588
Average volume (3 months)2,503,965
Market cap$1.4B
Dividend yield--
Data as of 10/20/2014

Growth & Valuation

Earnings growth (last year)-63.84%
Earnings growth (this year)-55.96%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.87
Price/Book27.98

Competitors

 Today’s
change
Today’s
% change
DYAXDyax Corp+0.13+1.29%
NKTRNektar Therapeutics+0.46+3.71%
ABCOAdvisory Board Co-0.14-0.28%
ARIAARIAD Pharmaceutical...+0.36+6.62%
Data as of 10/20/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$7.0M
Annual profit (last year)-$46.7M
Net profit margin-667.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
Chief Operating Officer &
Executive Vice President
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts